Magle Chemoswed Holding AB (publ) (STO:MAGLE)
0.3500
+0.0400 (12.90%)
Sep 4, 2026, 11:29 AM CET
Magle Chemoswed Holding AB Employees
Magle Chemoswed Holding AB had 150 employees as of June 30, 2026. The number of employees decreased by 8 or -5.06% compared to the same quarter last year.
Employees
150
Change
-8
Growth
-5.06%
Revenue / Employee
1.84M SEK
Profits / Employee
-1.75M SEK
Market Cap
9.38M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 150 | -8 | -5.06% |
| Mar 31, 2026 | 150 | 5 | 3.45% |
| Dec 31, 2025 | 144 | -3 | -2.04% |
| Sep 30, 2025 | 144 | -3 | -2.04% |
| Jun 30, 2025 | 158 | 11 | 7.48% |
| Mar 31, 2025 | 145 | 67 | 85.90% |
| Dec 31, 2024 | 147 | 69 | 88.46% |
| Sep 30, 2024 | 147 | 69 | 88.46% |
| Dec 31, 2023 | 78 | 3 | 4.00% |
| Dec 31, 2022 | 75 | 6 | 8.70% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ExpreS2ion Biotech Holding AB | 19 |
| Alligator Bioscience AB | 11 |
| Fluicell AB | 11 |
| AcouSort AB | 11 |
| NanoEcho AB | 5 |
| Aptahem AB | 3 |
| Modus Therapeutics Holding AB | 2 |
| Biosergen AB | 1 |
Magle Chemoswed Holding AB News
- 22 days ago - Magle Chemoswed Holding AB Quarterly report: Q2 2026 - Filings
- 3 months ago - Magle Chemoswed Holding AB Quarterly report: Q1 2026 - Filings
- 5 months ago - Magle Chemoswed Holding AB Quarterly report: Q4 2025 - Filings
- 5 months ago - Magle Chemoswed Holding AB Annual report: Q4 2025 - Filings
- 9 months ago - Magle Chemoswed Holding AB Quarterly report: Q3 2025 - Filings